79 related articles for article (PubMed ID: 30923318)
1. Quality of life and mood of older patients with acute myeloid leukemia (AML) receiving intensive and non-intensive chemotherapy.
El-Jawahri A; Abel GA; Traeger L; Waldman L; Markovitz N; VanDusen H; Fathi A; Steensma DP; LeBlanc TW; Horick NK; DeAngelo DJ; Wadleigh M; Hobbs G; Foster J; Brunner AM; Amrein P; Stone RM; Temel JS; Greer JA
Leukemia; 2019 Oct; 33(10):2393-2402. PubMed ID: 30923318
[TBL] [Abstract][Full Text] [Related]
2. Do quality of life or physical function at diagnosis predict short-term outcomes during intensive chemotherapy in AML?
Timilshina N; Breunis H; Brandwein JM; Minden MD; Gupta V; O'Neill S; Tomlinson GA; Buckstein R; Li M; Alibhai SMH
Ann Oncol; 2014 Apr; 25(4):883-888. PubMed ID: 24667720
[TBL] [Abstract][Full Text] [Related]
3. Assessment of an embedded primary care-derived electronic health record (EHR) frailty index (eFI) in older adults with acute myeloid leukemia.
Cheng JJ; Tooze JA; Callahan KE; Pajewski NM; Pardee TS; Reed DR; Klepin HD
J Geriatr Oncol; 2023 Sep; 14(7):101509. PubMed ID: 37454532
[TBL] [Abstract][Full Text] [Related]
4. The impact of remission status on patients' experiences with acute myeloid leukemia (AML): an exploratory analysis of longitudinal patient-reported outcomes data.
Kayastha N; Wolf SP; Locke SC; Samsa GP; El-Jawahri A; LeBlanc TW
Support Care Cancer; 2018 May; 26(5):1437-1445. PubMed ID: 29151174
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal changes in cognitive and physical function and health-related quality of life in older adults with acute myeloid leukemia.
Bhatt VR; Wichman C; Koll TT; Fisher AL; Wildes TM; Berger A; Armitage JO; Holstein SA; Maness LJ; Gundabolu K
J Geriatr Oncol; 2024 Jan; 15(1):101676. PubMed ID: 38000343
[TBL] [Abstract][Full Text] [Related]
6. Older Adults With Newly Diagnosed AML: Hot Topics for the Practicing Clinician.
Lai C; Bhansali RS; Kuo EJ; Mannis G; Lin RJ
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390018. PubMed ID: 37155946
[TBL] [Abstract][Full Text] [Related]
7. Quality of life in pediatric acute myeloid leukemia: Report from the Children's Oncology Group.
Nagarajan R; Gerbing R; Alonzo T; Johnston DL; Aplenc R; Kolb EA; Meshinchi S; Barakat LP; Sung L
Cancer Med; 2019 Aug; 8(9):4454-4464. PubMed ID: 31190442
[TBL] [Abstract][Full Text] [Related]
8. Trajectories of physical well-being among adults with acute myeloid leukemia.
Jensen-Battaglia M; Sohn MB; Consagra W; Wang Y; Zhang Z; LoCastro M; Davis J; Buettner K; Mortaz S; El-Jawahri AR; Loh KP
Blood Adv; 2024 Jun; 8(11):2612-2621. PubMed ID: 38429079
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy dose in obese AML patients: to cap or not to cap?
Percival ME; Medeiros BC
Leuk Res; 2015 Jan; 39(1):30-2. PubMed ID: 25499234
[No Abstract] [Full Text] [Related]
10. Tailoring a physical activity intervention to older adults receiving intensive chemotherapy for acute myeloid leukemia (AML): One size does not fit all.
Klepin HD; Tooze JA; Rejeski J; Mihalko S; Pardee TS; Demark-Wahnefried W; Powell BL; Geiger AM; Kritchevsky S
J Geriatr Oncol; 2022 May; 13(4):511-515. PubMed ID: 35487616
[No Abstract] [Full Text] [Related]
11. Itzykson R, Fournier E, Berthon C, et al. Genetic identification of patients with AML older than 60 years achieving long-term survival with intensive chemotherapy. Blood. 2021;138(7):507-519.
Blood; 2023 Jun; 141(26):3233. PubMed ID: 37383002
[No Abstract] [Full Text] [Related]
12. How to improve quality of life in patients with acute leukemia and comorbid ischemic heart disease treated with anthracycline-based induction chemotherapy.
Skrypnyk I; Maslova G; Lymanets T; Gusachenko I
Exp Oncol; 2019 Dec; 41(4):353-356. PubMed ID: 31868328
[TBL] [Abstract][Full Text] [Related]
13. Health-Related Quality of Life and Treatment of Older Adults with Acute Myeloid Leukemia: a Young International Society of Geriatric Oncology Review Paper.
Loh KP; Abdallah M; Kumar AJ; Neuendorff NR; Dahiya S; Klepin HD
Curr Hematol Malig Rep; 2019 Dec; 14(6):523-535. PubMed ID: 31776773
[TBL] [Abstract][Full Text] [Related]
14. Acute Myeloid Leukemia, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology.
Tallman MS; Wang ES; Altman JK; Appelbaum FR; Bhatt VR; Bixby D; Coutre SE; De Lima M; Fathi AT; Fiorella M; Foran JM; Hall AC; Jacoby M; Lancet J; LeBlanc TW; Mannis G; Marcucci G; Martin MG; Mims A; O'Donnell MR; Olin R; Peker D; Perl A; Pollyea DA; Pratz K; Prebet T; Ravandi F; Shami PJ; Stone RM; Strickland SA; Wieduwilt M; Gregory KM; ; Hammond L; Ogba N
J Natl Compr Canc Netw; 2019 Jun; 17(6):721-749. PubMed ID: 31200351
[TBL] [Abstract][Full Text] [Related]
15. Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial.
Wei AH; Montesinos P; Ivanov V; DiNardo CD; Novak J; Laribi K; Kim I; Stevens DA; Fiedler W; Pagoni M; Samoilova O; Hu Y; Anagnostopoulos A; Bergeron J; Hou JZ; Murthy V; Yamauchi T; McDonald A; Chyla B; Gopalakrishnan S; Jiang Q; Mendes W; Hayslip J; Panayiotidis P
Blood; 2020 Jun; 135(24):2137-2145. PubMed ID: 32219442
[TBL] [Abstract][Full Text] [Related]
16. Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial.
Stein EM; Fathi AT; DiNardo CD; Pollyea DA; Roboz GJ; Collins R; Sekeres MA; Stone RM; Attar EC; Frattini MG; Tosolini A; Xu Q; See WL; MacBeth KJ; de Botton S; Tallman MS; Kantarjian HM
Lancet Haematol; 2020 Apr; 7(4):e309-e319. PubMed ID: 32145771
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with quality of life of adult patients with acute leukemia and their family caregivers in China: a cross-sectional study.
Wang C; Yan J; Chen J; Wang Y; Lin YC; Hu R; Wu Y
Health Qual Life Outcomes; 2020 Jan; 18(1):8. PubMed ID: 31910863
[TBL] [Abstract][Full Text] [Related]
18. Ivosidenib induces deep durable remissions in patients with newly diagnosed IDH1-mutant acute myeloid leukemia.
Roboz GJ; DiNardo CD; Stein EM; de Botton S; Mims AS; Prince GT; Altman JK; Arellano ML; Donnellan W; Erba HP; Mannis GN; Pollyea DA; Stein AS; Uy GL; Watts JM; Fathi AT; Kantarjian HM; Tallman MS; Choe S; Dai D; Fan B; Wang H; Zhang V; Yen KE; Kapsalis SM; Hickman D; Liu H; Agresta SV; Wu B; Attar EC; Stone RM
Blood; 2020 Feb; 135(7):463-471. PubMed ID: 31841594
[TBL] [Abstract][Full Text] [Related]
19. Validated Instruments of Quality of Life (QOL) in Patients With Acute Myeloid Leukemia (AML) and Other Cancers.
Salas M; Henderson M; Wientzek-Fleischmann A; Islam Z; Tu N; Bilitou A; Elsharkawy M; Stellmacher U
Front Pharmacol; 2020; 11():1109. PubMed ID: 32792948
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Walking Exercise Program on Cancer-Related Fatigue in Patients with Acute Myeloid Leukemia Undergoing Chemotherapy.
Gheyasi F; Baraz S; Malehi A; Ahmadzadeh A; Salehi R; Vaismoradi M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1661-1666. PubMed ID: 31244285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
